rethinkTHC Search
Menu
Study breakdown

Systematic Review of 9 RCTs Finds CBD for Neurodevelopmental Disorders Shows Potential but Inconsistent Results

Systematic ReviewModerate evidence
The takeaway

Only 9 published RCTs exist testing CBD in neurodevelopmental disorders, with some positive signals but too inconsistent to guide clinical practice.

Parents of children with neurodevelopmental conditions, developmental pediatricians.

Only 9 RCTs exist for CBD across all neurodevelopmental disorders

What the researchers found

Nine RCTs across ADHD, autism, intellectual disability, Tourette's, and complex motor disorders showed some positive signals but inconsistent results. Evidence is undetermined.

Why it matters

Clinical CBD use in neurodevelopmental disorders is expanding despite an alarmingly thin evidence base.

The numbers in context

9 RCTs total across 5 conditions. Inconsistent results. Could not perform meta-analysis.

How the study worked

Systematic review searching four databases with PROSPERO registration. Only RCTs included.

What this study cannot tell us

Only 9 RCTs. High heterogeneity. No meta-analysis possible.

How to read the evidence

Systematic review limited by very few available RCTs.

When this study was published

Published 2023.

The bigger picture

Patients and families are making decisions in an evidence vacuum. This is concerning for vulnerable populations.

Questions still open

  • Which neurodevelopmental conditions are most likely to benefit?
  • What doses should future trials prioritize?

Common questions

Does CBD work for ADHD or autism?
Not enough evidence. Only 9 RCTs exist with inconsistent results.
Is CBD safe for these conditions?
Safety data is insufficient. More research is urgently needed.

Read the original research

A systematic review of cannabidiol trials in neurodevelopmental disorders.

Pharmacology, biochemistry, and behavior, 230, 173607

Citation

Parrella, Nina-Francecsa; Hill, Aron Thomas; Enticott, Peter Gregory; Barhoun, Pamela; Bower, Isabella Simone; Ford, Talitha Caitlyn. (2023). A systematic review of cannabidiol trials in neurodevelopmental disorders.. Pharmacology, biochemistry, and behavior, 230, 173607. https://doi.org/10.1016/j.pbb.2023.173607

Explore the wider topic